Protein name:
von Willebrand factor C and EGF domain-containing protein ;
Alternative:
HBxAg up-regulated gene 11 protein ;HBV X protein up-regulated gene 11 protein ;
Organism:
Human (Homo sapiens).
General Annotation
Function:
May be a regulatory element in the beta-catenin signaling pathway and a target for chemoprevention of hapatocellular carcinoma.
Subcellular Location:
Secreted
According to PubMed:16496348 is localized in the cytoplasm.
Protein Attributes:
50:
MWAGLLLRAA | CVALLLPGAP | ARGYTGRKPP | GHFAAERRRL | GPHVCLSGFG |
100:
SGCCPGWAPS | MGGGHCTLPL | CSFGCGSGIC | IAPNVCSCQD | GEQGATCPET |
150:
HGPCGEYGCD | LTCNHGGCQE | VARVCPVGFS | MTETAVGIRC | TDIDECVTSS |
200:
CEGHCVNTEG | GFVCECGPGM | QLSADRHSCQ | DTDECLGTPC | QQRCKNSIGS |
250:
YKCSCRTGFH | LHGNRHSCVD | VNECRRPLER | RVCHHSCHNT | VGSFLCTCRP |
300:
GFRLRADRVS | CEAFPKAVLA | PSAILQPRQH | PSKMLLLLPE | AGRPALSPGH |
350:
SPPSGAPGPP | AGVRTTRLPS | PTPRLPTSSP | SAPVWLLSTL | LATPVPTASL |
400:
LGNLRPPSLL | QGEVMGTPSS | PRGPESPRLA | AGPSPCWHLG | AMHESRSRWT |
450:
EPGCSQCWCE | DGKVTCEKVR | CEAACSHPIP | SRDGGCCPSC | TGCFHSGVVR |
500:
AEGDVFSPPN | ENCTVCVCLA | GNVSCISPEC | PSGPCQTPPQ | TDCCTCVPVR |
550:
CYFHGRWYAD | GAVFSGGGDE | CTTCVCQNGE | VECSFMPCPE | LACPREEWRL |
600:
GPGQCCFTCQ | EPTPSTGCSL | DDNGVEFPIG | QIWSPGDPCE | LCICQADGSV |
650:
SCKRTDCVDS | CPHPIRIPGQ | CCPDCSAGCT | YTGRIFYNNE | TFPSVLDPCL |
700:
SCICLLGSVA | CSPVDCPITC | TYPFHPDGEC | CPVCRDCNYE | GRKVANGQVF |
750:
TLDDEPCTRC | TCQLGEVSCE | KVPCQRACAD | PALLPGDCCS | SCPDSLSPLE |
800:
EKQGLSPHGN | VAFSKAGRSL | HGDTEAPVNC | SSCPGPPTAS | PSRPVLHLLQ |
850:
LLLRTNLMKT | QTLPTSPAGA | HGPHSLALGL | TATFPGEPGA | SPRLSPGPST |
900:
PPGAPTLPLA | SPGAPQPPPV | TPERSFSASG | AQIVSRWPPL | PGTLLTEASA |
950:
LSMMDPSPSK | TPITLLGPRV | LSPTTSRLST | ALAATTHPGP | QQPPVGASRG |
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Mouse
ELISA Kit for Human von Willebrand factor C and EGF domain-containing protein
ELISA Kit for Human von Willebrand factor C and EGF domain-containing protein
CLIA Kit for Human von Willebrand factor C and EGF domain-containing protein
CLIA Kit for Human von Willebrand factor C and EGF domain-containing protein
Polyclonal Antibody for Human von Willebrand factor C and EGF domain-containing protein
Polyclonal Antibody for Human von Willebrand factor C and EGF domain-containing protein
Monoclonal Antibody for Human von Willebrand factor C and EGF domain-containing protein
Monoclonal Antibody for Human von Willebrand factor C and EGF domain-containing protein
Protein for Human von Willebrand factor C and EGF domain-containing protein
Protein for Human von Willebrand factor C and EGF domain-containing protein
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T.
,
Suzuki Y.
,
Nishikawa T.
,
Otsuki T.
,
Sugiyama T.
,
Irie R.
,
Wakamatsu A.
,
Hayashi K.
,
Sato H.
,
Nagai K.
,
Kimura K.
,
Makita H.
,
Sekine M.
,
Obayashi M.
,
Nishi T.
,
Shibahara T.
,
Tanaka T.
,
Ishii S.
,
Yamamoto J.
,
Saito K.
,
Kawai Y.
,
Isono Y.
,
Nakamura Y.
,
Nagahari K.
,
Murakami K.
,
Yasuda T.
,
Iwayanagi T.
,
Wagatsuma M.
,
Shiratori A.
,
Sudo H.
,
Hosoiri T.
,
Kaku Y.
,
Kodaira H.
,
Kondo H.
,
Sugawara M.
,
Takahashi M.
,
Kanda K.
,
Yokoi T.
,
Furuya T.
,
Kikkawa E.
,
Omura Y.
,
Abe K.
,
Kamihara K.
,
Katsuta N.
,
Sato K.
,
Tanikawa M.
,
Yamazaki M.
,
Ninomiya K.
,
Ishibashi T.
,
Yamashita H.
,
Murakawa K.
,
Fujimori K.
,
Tanai H.
,
Kimata M.
,
Watanabe M.
,
Hiraoka S.
,
Chiba Y.
,
Ishida S.
,
Ono Y.
,
Takiguchi S.
,
Watanabe S.
,
Yosida M.
,
Hotuta T.
,
Kusano J.
,
Kanehori K.
,
Takahashi-Fujii A.
,
Hara H.
,
Tanase T.-O.
,
Nomura Y.
,
Togiya S.
,
Komai F.
,
Hara R.
,
Takeuchi K.
,
Arita M.
,
Imose N.
,
Musashino K.
,
Yuuki H.
,
Oshima A.
,
Sasaki N.
,
Aotsuka S.
,
Yoshikawa Y.
,
Matsunawa H.
,
Ichihara T.
,
Shiohata N.
,
Sano S.
,
Moriya S.
,
Momiyama H.
,
Satoh N.
,
Takami S.
,
Terashima Y.
,
Suzuki O.
,
Nakagawa S.
,
Senoh A.
,
Mizoguchi H.
,
Goto Y.
,
Shimizu F.
,
Wakebe H.
,
Hishigaki H.
,
Watanabe T.
,
Sugiyama A.
,
Takemoto M.
,
Kawakami B.
,
Yamazaki M.
,
Watanabe K.
,
Kumagai A.
,
Itakura S.
,
Fukuzumi Y.
,
Fujimori Y.
,
Komiyama M.
,
Tashiro H.
,
Tanigami A.
,
Fujiwara T.
,
Ono T.
,
Yamada K.
,
Fujii Y.
,
Ozaki K.
,
Hirao M.
,
Ohmori Y.
,
Kawabata A.
,
Hikiji T.
,
Kobatake N.
,
Inagaki H.
,
Ikema Y.
,
Okamoto S.
,
Okitani R.
,
Kawakami T.
,
Noguchi S.
,
Itoh T.
,
Shigeta K.
,
Senba T.
,
Matsumura K.
,
Nakajima Y.
,
Mizuno T.
,
Morinaga M.
,
Sasaki M.
,
Togashi T.
,
Oyama M.
,
Hata H.
,
Watanabe M.
,
Komatsu T.
,
Mizushima-Sugano J.
,
Satoh T.
,
Shirai Y.
,
Takahashi Y.
,
Nakagawa K.
,
Okumura K.
,
Nagase T.
,
Nomura N.
,
Kikuchi H.
,
Masuho Y.
,
Yamashita R.
,
Nakai K.
,
Yada T.
,
Nakamura Y.
,
Ohara O.
,
Isogai T.
,
Sugano S.
more...
Nat. Genet.36:40-45(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
tissue :
Teratocarcinoma .
2.
Mural R.J.
,
Istrail S.
,
Sutton G.G.
,
Florea L.
,
Halpern A.L.
,
Mobarry C.M.
,
Lippert R.
,
Walenz B.
,
Shatkay H.
,
Dew I.
,
Miller J.R.
,
Flanigan M.J.
,
Edwards N.J.
,
Bolanos R.
,
Fasulo D.
,
Halldorsson B.V.
,
Hannenhalli S.
,
Turner R.
,
Yooseph S.
,
Lu F.
,
Nusskern D.R.
,
Shue B.C.
,
Zheng X.H.
,
Zhong F.
,
Delcher A.L.
,
Huson D.H.
,
Kravitz S.A.
,
Mouchard L.
,
Reinert K.
,
Remington K.A.
,
Clark A.G.
,
Waterman M.S.
,
Eichler E.E.
,
Adams M.D.
,
Hunkapiller M.W.
,
Myers E.W.
,
Venter J.C.
more...
Submitted (2005-07) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)
tissue :
Lymph .
4.
"Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis."
Lian Z.
,
Liu J.
,
Li L.
,
Li X.
,
Tufan S.N.L.
,
Clayton M.
,
Wu M.-C.
,
Wang H.-Y.
,
Arbuthnot P.
,
Kew M.
,
Feitelson M.A.
Neoplasia5:229-244(2003)
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 73-955 (ISOFORM 1)
5.
"Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin."
Lian Z.
,
Liu J.
,
Li L.
,
Li X.
,
Clayton M.
,
Wu M.-C.
,
Wang H.-Y.
,
Arbuthnot P.
,
Kew M.
,
Fan D.
,
Feitelson M.A.
Hepatology43:415-424(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION;SUBCELLULAR LOCATION;INDUCTION BY HBXAG;TISSUE SPECIFICITY